How Can We Help?
Skip to content
Researcher looking at a book
Access ADME Logo

In Vivo & Radiolabeling

In vivo and radiolabeled compound studies are necessary for distribution data, dosing calculations for first in-human studies, bridging in vitro PK and toxicology data, and much more. Find resources here relating to our in vivo and radiolabeling services offered byt the Drug Development Soluctions Center. The Center offers GLP and non-GLP animal studies to investigate your drug’s pharmacokinetics as well as top-tier radioisotope (RI) compound labeling services for pharmaceuticals. For more information about these services, visit our In Vivo ADME/PK page.

 

Webinars

RI-ADE ADME 101: Non-clinical pharmacokinetics studies using radio-labeled compounds

Presenter: Satoshi Ito, Drug Development Solutions Center ADME Group Manager, Sekisui Medical Radio-labeled compounds can be used to provide important information during the drug development process....
Webinars

Filing an IND and Beyond: Development of CTD Section 2.6.4, Pharmacokinetics Written Summary

Presenter: Griff Humphreys, Ph.D, XenoTech Consultant Recorded keynote presentation from XenoTech’s 2022 Seminar Series. Learn about what this important section consists of, the studies that...
Webinars

The Role of In Vitro Assays in Selecting the Right Species for Your Small Molecule Program

Presenters: Andrew G. Taylor, Ph.D., Manager of Technical Support for Services at XenoTech and Scott Boley, Ph.D., DABT, Senior Vice President of Research at Sinclair Research...
Blog

Toxicokinetic (TK) Analysis for Preclinical Drug Development

The main goal of preclinical toxicokinetic (TK) studies is to establish a correlation between a candidate compound’s concentration or dose...

Blog

Missing Out on Annual ‘Comforting of the Soul’

As we begin this summer, many of us are grieving opportunities lost for parties and pool days with friends and...

Blog

What You Need to Know About Micro-Autoradiography (mARG) Distribution Studies

In vivo determination of drug localization in tissue can be uniquely informative to drug developers investigating distribution within the context of...

Blog

DDSC In Vivo ADME Expertise Providing Cost Savings

ADME studies are a vital part of the drug development process, and therefore, deciding where and how to perform these studies...

Blog

Mass Balance Studies: What You Need and Why You Need It

In vivo mass balance studies are an important element of nonclinical drug development, to inform first in-human (FIH) studies and to...

Blog

Why You Need QWBA for Human Radiolabeled ADME Studies

A quantitative whole body autoradiography (QWBA) study provides data required for Human Radiolabeled ADME Studies1. Quantitative whole body autoradiography (QWBA) is an in...

Blog

In Vivo ADME: What You Need and Why You Need It

When putting together a data package for regulatory approval by the FDA, EMA, or PMDA, there is a lot to...

Blog

The Story of Us

This year at XenoTech we celebrate our 25th birthday, and our partner in Japan turns 64! Looking back over our history,...

Blog

Studies in Japan: Easier & More Beneficial than You Might Think

XenoTech is well-known to pharmaceutical companies and toxicology academics alike for unparalleled experience in quality in vitro ADME/DMPK/DDI studies and complementary products,...

Blog

To GLP or not to GLP?

That is the question. . . Knowing the answer may save you time and money Good Laboratory Practices (GLP) are...

Blog

Choosing a Relevant Small Animal Model for Pharmacokinetic or Toxicity Studies

Choosing the most suitable small animal model is crucial for pharmacokinetic and/or toxicology studies in order to get usable, relevant data. Due to potential...